ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 771 filers reported holding ASTRAZENECA PLC in Q2 2021. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $433,168 | +3.6% | 5,554 | -10.0% | 0.02% | -4.8% |
Q1 2024 | $418,169 | +5.2% | 6,172 | +4.6% | 0.02% | -8.7% |
Q4 2023 | $397,510 | -0.7% | 5,901 | -0.2% | 0.02% | -23.3% |
Q3 2023 | $400,321 | +12.1% | 5,911 | +18.5% | 0.03% | +20.0% |
Q2 2023 | $357,144 | +0.9% | 4,990 | -2.2% | 0.02% | 0.0% |
Q1 2023 | $353,999 | -45.8% | 5,100 | -47.1% | 0.02% | -50.0% |
Q4 2022 | $653,559 | +139.4% | 9,639 | +93.4% | 0.05% | +117.4% |
Q3 2022 | $273,000 | +4.6% | 4,983 | +26.3% | 0.02% | +9.5% |
Q2 2022 | $261,000 | -10.3% | 3,945 | -10.0% | 0.02% | +5.0% |
Q1 2022 | $291,000 | +13.7% | 4,384 | -0.3% | 0.02% | +17.6% |
Q4 2021 | $256,000 | +7.6% | 4,397 | +10.8% | 0.02% | 0.0% |
Q3 2021 | $238,000 | +3.5% | 3,969 | +3.4% | 0.02% | -5.6% |
Q2 2021 | $230,000 | -5.7% | 3,837 | -21.3% | 0.02% | -28.0% |
Q4 2020 | $244,000 | -82.5% | 4,873 | -80.8% | 0.02% | -76.6% |
Q3 2020 | $1,391,000 | +465.4% | 25,381 | +414.0% | 0.11% | +245.2% |
Q4 2019 | $246,000 | – | 4,938 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |